Top Markets
Coin of the day
Comera Life Sciences Holdings, Inc. Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

CMRAW
Rang in aandelen #41594
Comera Life Sciences Holdings, Inc. is an early-stage life sciences company... Comera Life Sciences Holdings, Inc. is an early-stage life sciences company dedicated to developing its own innovative therapeutics. These treatments leverage its unique SQore formulation platform, which is engineered to convert biologics typically administered intravenously (IV) into convenient subcutaneous (SQ) versions. The company's pipeline currently features two primary drug candidates: CLS-001, an improved biologic in preclinical development, targets Crohn's and Ulcerative Colitis; and CLS-002, also in preclinical stages, is an enhanced biologic aimed at various oncological indications. Established in 2014, Comera Life Sciences is based in Woburn, Massachusetts.
Aandeelprijs
$0.0008
Laatst gesynchroniseerd: 2024-03-14
Marktkapitalisatie
$15.27K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Comera Life Sciences Holdings, Inc. (CMRAW)

Categorie

Dividendrendementgeschiedenis voor Comera Life Sciences Holdings, Inc. (CMRAW)
Het dividendrendement (TTM) van Comera Life Sciences Holdings, Inc. (aandelsymbool: CMRAW) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Comera Life Sciences Holdings, Inc. (CMRAW) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten